Clinical trial

Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP)…

NCT00315640 · Alcon Research, Industry · Completed

Key facts

NCT number NCT00315640
Title Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
Official title A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
Lead sponsor Alcon Research, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Eye Diseases
Intervention type Drug, Other
Interventions Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Suspension Depot, 30 mg/mL, 60 mg/mL, Anecortave Acetate Vehicle
Enrollment 70
Start date Dec 1, 2005
Primary completion Jul 1, 2009
Completion Jul 1, 2009
First posted Apr 19, 2006
Last update posted Nov 28, 2012
Countries Brazil, Hungary, Italy, Netherlands, Puerto Rico, Spain, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies